Recruiting Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease NCT07252050 Conditions Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +11 more Locations Children's Hospital of Colorado — Aurora, Colorado, United States Children's Healthcare of Atlanta — Atlanta, Georgia, United States Manning Family Children's — New Orleans, Louisiana, United States Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States View Trial Details
Recruiting BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation NCT07246031 Conditions Graft -Versus-host-disease, Graft vs Host Disease, Haploidentical Stem Cell Transplantation, +3 more Locations Peking University People's Hospital — Beijing, Beijing Municipality, China View Trial Details
Not Yet Recruiting Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies NCT07193420 Conditions GVHD - Graft-Versus-Host Disease, Graft vs Host Disease, HSCT, +2 more Locations Saint Antoine Hospital - Hematology Department — Paris, France View Trial Details
Completed Impact of Donor-recipient ABO Matching on Haploidentical Stem Cell Transplantation NCT05103995 Conditions Haploidentical Stem Cell Transplantation, Hematologic Diseases, Hematologic Neoplasms, +4 more Locations The first Affiliated Hospital of Zhejiang University — Hangzhou, Zhejiang, China Affiliated Jinhua hospital of Zhejiang University — Jinhua, Zhejiang, China View Trial Details
